Eli Lilly Revenue, Growth & Competitor Profile

DBA LILLY ELI & CO

Company Profile & Annual Report for Eli Lilly

Access the complete profile.

Eli Lilly Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	Lilly Corporate Ctr Indianapolis, IN 46285

Eli Lilly's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Eli Lilly's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Eli Lilly is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Eli Lilly is a publicly traded company on NYQ using the ticker symbol LLY. Detailed information on company financials and operating reports can be found here: NYQ: LLY

Eli Lilly Annual Revenue and Growth Rate

Eli Lilly	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Eli Lilly's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Eli Lilly is developing and marketing. Eli Lilly's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TWILGECY Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases	01/25/2024
WHAT TIME HIDES Providing medical information in the field of Alzheimer's and related diseases.	01/16/2024
CONNECTAD Educational services, namely, programs for healthcare personnel about clinical cases and communication practices in the area of Alzheimer disease	01/16/2024

See all trademarks and details in the Full Report.

Market Share of Eli Lilly's Largest Competitors

A competitive analysis shows these companies are in the same general field as Eli Lilly, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Eli Lilly. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELI LILLY	Indianapolis, IN	100
ROCHE DIAGNOSTICS	Indianapolis, IN	5
EXELEAD	Indianapolis, IN	1
3C	Fishers, IN	1
POINT BIOPHARMA	Indianapolis, IN	0
SENTRY BIOPHARMA SERVICES	Indianapolis, IN	0

Future Competition: Eli Lilly's Fastest Growing Competitors

These companies are in the same general field as Eli Lilly and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)